Search filters

List of works by Francesca Romana Ponziani

Anticoagulants in Cirrhotic Patients: Controversies and Certainties in PVT Management ⬇️

scientific article published on July 1, 2011

Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications

scientific article published on 06 June 2018

Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation

scientific article

Diagnosis and treatment of small intestinal bacterial overgrowth

scientific article published on 4 December 2015

Diagnosis of bowel diseases: the role of imaging and ultrasonography.

scientific article

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma

scientific article published on 10 May 2019

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

scientific article published on 25 June 2013

Effect of liver transplantation on intestinal permeability and correlation with infection episodes

scientific article published on 26 June 2020

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications

scientific article

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy

scientific article published in 2023

Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study

scientific article published on 26 December 2019

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

scientific article published on 28 July 2020

Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease

scientific article published on 03 February 2020

Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.

scientific article

Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma

scientific article published on 20 January 2016

Letter to the Editor: Restructuring the Gut Microbiota of Patients with Cirrhosis After HCV Eradication: A Matter of Time?

scientific article published in 2021

Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism?

scientific article published on 01 August 2019

Letter: liver involvement and mortality in COVID-19 patients - authors' reply

scientific article published on 01 October 2020

Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19

scientific article published on 01 September 2020

Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients

scientific article published on 06 July 2020

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

scientific article published on 11 March 2014

Management of hepatitis C virus infection recurrence after liver transplantation: an overview.

scientific article published on January 2011

Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit†

scientific article published on 04 December 2014

Physiology and pathophysiology of liver lipid metabolism.

scientific article published on 12 June 2015

Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up

scientific article published on 27 January 2014

Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban

scientific article

Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.

scientific article published on December 2012

Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort

scientific article published on 16 April 2015

Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.

scientific article

Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges

scientific article published on 12 October 2020

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

scientific article

The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma.

scientific article published on 27 October 2011

Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.

scientific article published on 23 April 2009

Treatment of early stage chronic hepatitis C virus infection.

scientific article

Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers

scientific article published on 11 December 2012

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

scientific article published on 21 February 2012

Use and indications of cholestyramine and bile acid sequestrants.

scientific article published on 08 July 2011

What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective

scientific article

Paulina is supported by:

About Paulina

Help